Black Diamond Therapeutic...

NASDAQ: BDTX · Real-Time Price · USD
2.78
-0.01 (-0.36%)
At close: Aug 15, 2025, 12:45 PM

Black Diamond Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
343K 437K 3.24M 2.22M
Gross Profit
n/a -437K -3.24M -2.22M
Operating Income
-78.78M -86.46M -92.83M -126.87M
Interest Income
2.18M 1.92M 2.03M 3.46M
Pretax Income
-69.68M -82.44M -88.92M -125.6M
Net Income
-69.68M -82.44M -84.52M -123.2M
Selling & General & Admin
27.47M 27.11M 28.39M 30.04M
Research & Development
51.31M 58.91M 64.44M 96.83M
Other Expenses
n/a n/a -354K -2.19M
Operating Expenses
78.78M 86.46M 92.83M 126.87M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 86.46M 92.83M 126.87M
Income Tax Expense
n/a n/a -4.4M -2.39M
Shares Outstanding (Basic)
55.03M 43.95M 36.33M 36.19M
Shares Outstanding (Diluted)
55.03M 43.95M 36.33M 36.19M
EPS (Basic)
-1.27 -1.88 -2.33 -3.4
EPS (Diluted)
-1.27 -1.88 -2.33 -3.4
EBITDA
-69.33M -86.02M -92.32M -126.67M
EBIT
-69.68M -86.46M -92.83M -126.87M
Depreciation & Amortization
343K 437K 3.24M 2.22M